FDA establishes new advisory committee for genetic metabolic disease treatments
The FDA is assembling a new advisory committee to evaluate potential treatments for genetic metabolic diseases, the agency announced Tuesday. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
